BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31725651)

  • 1. Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B.
    Liu L; Li P; Mi Y; Liu Y; Liu Y; Zhang P
    Medicine (Baltimore); 2019 Nov; 98(46):e17945. PubMed ID: 31725651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
    Kim D; Kim W; Joo SK; Bae JM; Kim JH; Ahmed A
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):123-131.e1. PubMed ID: 28823829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
    Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.
    Huang Y; Gan Q; Lai R; Wang W; Guo S; Sheng Z; Chen L; Guo Q; Cai W; Wang H; Zhao G; Cao Z; Xie Q
    Front Cell Infect Microbiol; 2021; 11():733348. PubMed ID: 35111690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
    Carulli L; Ballestri S; Lonardo A; Lami F; Violi E; Losi L; Bonilauri L; Verrone AM; Odoardi MR; Scaglioni F; Bertolotti M; Loria P
    Intern Emerg Med; 2013 Jun; 8(4):297-305. PubMed ID: 21559749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD.
    Hu DS; Zhu SH; Liu WY; Pan XY; Zhu PW; Li YY; Zheng KI; Ma HL; You J; Targher G; Byrne CD; Chen YP; Zheng MH
    Diabetes Metab; 2020 Nov; 46(6):496-503. PubMed ID: 32035968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
    Guo Z; Li M; Han B; Qi X
    Dig Liver Dis; 2018 Nov; 50(11):1153-1162. PubMed ID: 30224316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
    Manka P; Bechmann L; Best J; Sydor S; Claridge LC; Coombes JD; Canbay A; Moeller L; Gerken G; Wedemeyer H; Syn WK
    Dig Dis Sci; 2019 Aug; 64(8):2351-2358. PubMed ID: 31155687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B.
    Li MR; Li JZ; Wang DH; Li TY; Ye LH; Liang XJ; Zhang HC; Liu ZQ; Zhang XD; Li JQ; Liu YY; Pan CQ; Dai EH
    Scand J Gastroenterol; 2024 Apr; 59(4):445-455. PubMed ID: 38053282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
    Alqahtani SA; Yilmaz Y; El-Kassas M; Alswat K; Sanai F; AlZahrani M; Abaalkhail F; AlShaikh M; Al-Hamoudi WK; Nader F; Stepanova M; Younossi ZM;
    J Viral Hepat; 2024 Jun; 31(6):300-308. PubMed ID: 38622910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
    Liang J; Han T; Gao YT; Jing L; Ma Z
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
    Liang J; Liu F; Wang F; Han T; Jing L; Ma Z; Gao Y
    Biomed Res Int; 2017; 2017():8793278. PubMed ID: 28349067
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.
    Choi HSJ; Brouwer WP; Zanjir WMR; de Man RA; Feld JJ; Hansen BE; Janssen HLA; Patel K
    Hepatology; 2020 Feb; 71(2):539-548. PubMed ID: 31309589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment.
    Chang XJ; Shi YW; Wang J; Liu HB; Chen Y; Zhu XN; Chen YP; Yu ZJ; Shang QH; Tan L; Li Q; Jiang L; Xiao GM; Chen L; Lu W; Hu XY; Long QH; An LJ; Zou ZY; Wong VW; Yang YP; Fan JG
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):416-425. PubMed ID: 34275749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects.
    Liu Y; Wang W; Yu X; Qi X
    Ann Hepatol; 2018 Aug; 17(5):779-788. PubMed ID: 30145565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
    Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    D'Ambrosio R; Campi I; Maggioni M; Perbellini R; Giammona E; Stucchi R; Borghi M; Degasperi E; De Silvestri A; Persani L; Fugazzola L; Lampertico P
    PLoS One; 2021; 16(4):e0249614. PubMed ID: 33822817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
    Yang RX; Hu CX; Sun WL; Pan Q; Shen F; Yang Z; Su Q; Xu GW; Fan JG
    Sci Rep; 2017 Sep; 7(1):10517. PubMed ID: 28874844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
    van den Berg EH; van Tienhoven-Wind LJ; Amini M; Schreuder TC; Faber KN; Blokzijl H; Dullaart RP
    Metabolism; 2017 Feb; 67():62-71. PubMed ID: 28081779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.